Skip to content

Effects of Remimazolam on the intracranial pressure in Patients Undergoing Laparoscopic Hysterectomy in the Trendelenburg Position

Effects of Remimazolam on the intracranial pressure in Patients Undergoing Laparoscopic Hysterectomy in the Trendelenburg Position

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101025
Enrollment
Unknown
Registered
2025-04-18
Start date
2023-10-08
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic hysterectomy

Interventions

Remimazolam Group: Anesthesia induction and maintenance with remimazolam
Propofol Group: Anesthesia induction and maintenance with propofol

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 18y <= age <65y; 18kg/m2 = BMI <28kg/m^2; (2) American Society of Anesthesiologists (ASA) class I-II; 3) Proposed elective laparoscopic hysterectomy. (4) Understanding the study content and obtaining informed consent before surgery, and signing the informed consent form;

Exclusion criteria

Exclusion criteria: 1) Patients with known hypersensitivity to remimazolam or with previous history of severe allergy and family history; 2) Patients with long-term use of non-steroidal anti-inflammatory drugs, narcotic analgesics or sedatives and alcoholism; (3) Patients with severe cardiac, pulmonary, hepatic, renal function abnormalities or severe cardiovascular and cerebrovascular diseases; (4) Patients with central nervous system diseases and surgical history, psychiatric diseases and disorders of consciousness; (5) Patients with eye diseases (glaucoma, cataract, blindness, etc.) and history of eye surgery;

Design outcomes

Primary

MeasureTime frame
optic sheath nerve diameter;

Secondary

MeasureTime frame
blood pressure;heart rate;BIS;partial pressure of carbon dioxide at end-expiration;

Countries

China

Contacts

Public ContactZhenyi Chen

The First Affiliated Hospital of Xiamen University

Chard178@163.com+86 136 0692 2087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026